These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 10336580

  • 1. The influence of CYP2D6 activity on the kinetics of propafenone enantiomers in Chinese subjects.
    Cai WM, Chen B, Cai MH, Chen Y, Zhang YD.
    Br J Clin Pharmacol; 1999 May; 47(5):553-6. PubMed ID: 10336580
    [Abstract] [Full Text] [Related]

  • 2. CYP2D6 phenotype determines pharmacokinetic variability of propafenone enantiomers in 16 HAN Chinese subjects.
    Cai WM, Chen B, Cai MH, Zhang YD.
    Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):720-4. PubMed ID: 10678105
    [Abstract] [Full Text] [Related]

  • 3. Fluoxetine impairs the CYP2D6-mediated metabolism of propafenone enantiomers in healthy Chinese volunteers.
    Cai WM, Chen B, Zhou Y, Zhang YD.
    Clin Pharmacol Ther; 1999 Nov; 66(5):516-21. PubMed ID: 10579479
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of CYP2D6 polymorphisms on the pharmacokinetics of propafenone and its two main metabolites.
    Rouini MR, Afshar M.
    Therapie; 2017 Jun; 72(3):373-382. PubMed ID: 28087064
    [Abstract] [Full Text] [Related]

  • 6. The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment.
    Jazwinska-Tarnawska E, Orzechowska-Juzwenko K, Niewinski P, Rzemislawska Z, Loboz-Grudzien K, Dmochowska-Perz M, Slawin J.
    Int J Clin Pharmacol Ther; 2001 Jul; 39(7):288-92. PubMed ID: 11471772
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings.
    Labbé L, O'Hara G, Lefebvre M, Lessard E, Gilbert M, Adedoyin A, Champagne J, Hamelin B, Turgeon J.
    Clin Pharmacol Ther; 2000 Jul; 68(1):44-57. PubMed ID: 10945315
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Capillary electrophoretic investigation of the enantioselective metabolism of propafenone by human cytochrome P-450 SUPERSOMES: Evidence for atypical kinetics by CYP2D6 and CYP3A4.
    Afshar M, Thormann W.
    Electrophoresis; 2006 Apr; 27(8):1526-36. PubMed ID: 16609933
    [Abstract] [Full Text] [Related]

  • 10. Stereoselective pharmacokinetics of propafenone and its major metabolites in healthy Chinese volunteers.
    Chen X, Zhong D, Blume H.
    Eur J Pharm Sci; 2000 Mar; 10(1):11-6. PubMed ID: 10699379
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Simultaneous determination of propafenone and 5-hydroxypropafenone enantiomers in plasma by chromatography on an amylose derived chiral stationary phase.
    Pires de Abreu LR, Lanchote VL, Bertucci C, Cesarino EJ, Bonato PS.
    J Pharm Biomed Anal; 1999 Jun; 20(1-2):209-16. PubMed ID: 10704025
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of a propafenone metabolic ratio as a measure of CYP2D6 activity.
    Anzenbacherová E, Anzenbacher P, Perlik F, Kvetina J.
    Int J Clin Pharmacol Ther; 2000 Sep; 38(9):426-9. PubMed ID: 11020029
    [Abstract] [Full Text] [Related]

  • 16. Enantioselective determination of propafenone and its metabolites in human plasma by liquid chromatography-mass spectrometry.
    Zhong D, Chen X.
    J Chromatogr B Biomed Sci Appl; 1999 Jan 08; 721(1):67-75. PubMed ID: 10027638
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Simultaneous modeling of pharmacokinetics and pharmacodynamics of propafenone in healthy subjects.
    Cai WM, Zhang YD, Chen B, Cai MH, Luo JP, Ling SS.
    Acta Pharmacol Sin; 2001 Oct 08; 22(10):956-60. PubMed ID: 11749782
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexiline.
    Davies BJ, Herbert MK, Coller JK, Somogyi AA, Milne RW, Sallustio BC.
    Br J Clin Pharmacol; 2008 Mar 08; 65(3):347-54. PubMed ID: 17875193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.